Industries > Pharma > Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2014-2024
Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2014-2024
Pre-filled syringes and related devices – discover leading companies’ revenue prospects
How are companies in the pre-filled syringe industry performing? Visiongain’s report gives you data, analysis and discussions for producers of those drug delivery devices.
Our updated study lets you assess companies in the pre-filled (ready-to-fill) syringe industry and market, showing you their prospects to 2024. There you see financial results, interviews, trends, opportunities and sales predictions.
That way you discover potentials of established and emerging companies. Read on to scan those organisations and see what their future market could be worth.
Forecasts and discussions to help you stay ahead in knowledge and authority
Our new study assesses 19 top companies – and analyses that overall industry – with recent results, revenue forecasts and growth rates. There you gain 76 tables, 43 charts and two interviews.
You also get qualitative analyses, including research and development (R&D). Our work lets you assess the most lucrative applications of those drug delivery technologies. You see opportunities for biological drug makers and suppliers of medical injection devices.
That way you stay ahead in knowledge of the industry and market for these medical devices, helping your influence:
• Plastic syringes
• Glass syringes
• Related injection products and disposable (single-use) systems for injecting drugs.
And the following sections highlight what our new investigation gives you.
Company profiles – what firms hold most potential and how do they succeed?
Our report profiles 19 leading companies across four sectors of the pre-filled injection devices market. The content of each discussion differs, depending on the company. In general, then, a profile contains the following information:
• Overview of the firm, including its history in the pre-filled injection devices market
• Discussion of the company’s pre-filled injection device product or service portfolio, including main clients
• Analysis of the company’s recent financial performance, for overall revenue and, where possible, pre-filled injection device sales
• Assessment of its recent developments there – e.g. acquisitions, expansions, launches and collaborations with the pharmaceutical industry
• Prospects of the company – strengths over competitors and opportunities for sales
• Prediction of revenue for the period 2014-2024 (for nine companies).
Those surveys show how product and service demand has changed in recent years, as well as explaining how those needs change from 2014.
Prospects for leading pre-filled syringe manufacturers
That study gives you discussions and financial analyses for leading developers and producers of pre-filled syringes:
• Becton, Dickinson & Co. (BD)
• Nuova Ompi
• Unilife Corporation.
There you discover what the future holds for those pharma-related medical device companies, seeing how they compare and compete. You find where the best prospects for business exist.
Suppliers and users of pre-filled injection systems will benefit from 2014. Next, our work analyses developers, producers and providers of associated technology.
Outlooks for manufacturers of pre-filled syringe components
The report shows you developments and revenue prospects for leading producers of syringe components:
• Aptar Stelmi
• Datwyler Group
• West Pharmaceutical Services.
There you explore opportunities for companies making plungers, needle shields, tip caps and related products.
Hear where the money lies. Our work shows you where sales growth can occur. Many opportunities remain, with expanding revenues likely from 2014 to 2024.
Potentials of leading pen injector and autoinjector producers
In our study you also see commercial outlooks for top manufacturers of pen injectors and autoinjectors:
• Owen Mumford
• SHL Group
There you assess product portfolios, strategies and revenue prospects. You also investigate associated organisations and competition. Our work shows you possibilities for advancing technologies and raising sales.
Contract manufacturers in that parenteral drug delivery
Our work also assesses contract manufacturing organisations (CMOs) in that field. There you explore these production service providers:
• Hospira One2One
• Vetter Pharma
• Laboratorios Farmacéuticos ROVI
• Albany Molecular Research Inc (AMRI).
So you assess competitive outlooks of CMOs. You also scan applications for biological drugs (biologics), lyophilisation and dual-chamber syringes.
Value of that market in 2018 – what’s possible?
Our analysis predicts overall world revenues for those pre-filled injection devices – the drug delivery technology – will reach $5.9bn in 2018. Those sales will expand further to 2024.
Greater use of biologics and vaccines raise demand for parenteral delivery systems. Many opportunities exist, especially for plastic syringes and ready-to-use containment of labile drugs and other complex pharmaceuticals. The study explains.
What about applications? Incidence of diabetes and expansion of the home healthcare market stimulate demand for pre-filled drug injection products. See how and where.
So medical injection systems giving improved clinical efficacy, safety and convenience will achieve success. There you discover prospects from 2014 to 2024 for that industry.
Ways Medical Device Leader Series: Top Pre-Filled Injection Device Manufacturers 2014-2024 helps
In particular our new investigation gives you this knowledge:
• Profiles of 19 leading companies – assess products, services, activities, opinions and results
• Competition and opportunities – explore what affects that industry, finding what influences its sales and determines its future
• Revenues to 2024 for that market at world level – discover prospects for sales growth of the overall industry and nine of its companies.
That report assesses prospects for companies in each segment via Porter’s five forces analysis. It also examines strengths, weaknesses, opportunities and threats (SWOT forces) those organisations face.
Information found nowhere else, benefiting your searches, planning and decisions
That work gives independent analysis. There you receive business intelligence found only in our report, seeing where technological and financial prospects are most rewarding.
With our study you are less likely to fall behind in knowledge or miss opportunity. See there how you could benefit your research, analyses and decisions, also saving time and getting recognition for technological and commercial insight.
Our new investigation is for everyone needing analysis of the industry and market for drug delivery via injections. There you find data, trends, opportunities and sales predictions. So please get our report here now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6